Cargando…

Proteotypic classification of spontaneous and transgenic mammary neoplasms

INTRODUCTION: Mammary tumors in mice are categorized by using morphologic and architectural criteria. Immunolabeling for terminal differentiation markers was compared among a variety of mouse mammary neoplasms because expression of terminal differentiation markers, and especially of keratins, provid...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikaelian, Igor, Blades, Natalie, Churchill, Gary A, Fancher, Karen, Knowles, Barbara B, Eppig, Janan T, Sundberg, John P
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064077/
https://www.ncbi.nlm.nih.gov/pubmed/15535849
http://dx.doi.org/10.1186/bcr930
_version_ 1782123283675611136
author Mikaelian, Igor
Blades, Natalie
Churchill, Gary A
Fancher, Karen
Knowles, Barbara B
Eppig, Janan T
Sundberg, John P
author_facet Mikaelian, Igor
Blades, Natalie
Churchill, Gary A
Fancher, Karen
Knowles, Barbara B
Eppig, Janan T
Sundberg, John P
author_sort Mikaelian, Igor
collection PubMed
description INTRODUCTION: Mammary tumors in mice are categorized by using morphologic and architectural criteria. Immunolabeling for terminal differentiation markers was compared among a variety of mouse mammary neoplasms because expression of terminal differentiation markers, and especially of keratins, provides important information on the origin of neoplastic cells and their degree of differentiation. METHODS: Expression patterns for terminal differentiation markers were used to characterize tumor types and to study tumor progression in transgenic mouse models of mammary neoplasia (mice overexpressing Neu (Erbb2), Hras, Myc, Notch4, SV40-TAg, Tgfa, and Wnt1), in spontaneous mammary carcinomas, and in mammary neoplasms associated with infection by the mouse mammary tumor virus (MMTV). RESULTS: On the basis of the expression of terminal differentiation markers, three types of neoplasm were identified: first, simple carcinomas composed exclusively of cells with a luminal phenotype are characteristic of neoplasms arising in mice transgenic for Neu, Hras, Myc, Notch4, and SV40-TAg; second, 'complex carcinomas' displaying luminal and myoepithelial differentiation are characteristic of type P tumors arising in mice transgenic for Wnt1, neoplasms arising in mice infected by the MMTV, and spontaneous adenosquamous carcinomas; and third, 'carcinomas with epithelial to mesenchymal transition (EMT)' are a characteristic feature of tumor progression in Hras-, Myc-, and SV40-TAg-induced mammary neoplasms and PL/J and SJL/J mouse strains, and display de novo expression of myoepithelial and mesenchymal cell markers. In sharp contrast, EMT was not detected in papillary adenocarcinomas arising in BALB/cJ mice, spontaneous adenoacanthomas, neoplasms associated with MMTV-infection, or in neoplasms arising in mice transgenic for Neu and Wnt1. CONCLUSIONS: Immunohistochemical profiles of complex neoplasms are consistent with a stem cell origin, whereas simple carcinomas might originate from a cell committed to the luminal lineage. In addition, these results suggest that the initiating oncogenic events determine the morphologic features associated with cancer progression because EMT is observed only in certain types of neoplasm.
format Text
id pubmed-1064077
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-10640772005-03-11 Proteotypic classification of spontaneous and transgenic mammary neoplasms Mikaelian, Igor Blades, Natalie Churchill, Gary A Fancher, Karen Knowles, Barbara B Eppig, Janan T Sundberg, John P Breast Cancer Res Research Article INTRODUCTION: Mammary tumors in mice are categorized by using morphologic and architectural criteria. Immunolabeling for terminal differentiation markers was compared among a variety of mouse mammary neoplasms because expression of terminal differentiation markers, and especially of keratins, provides important information on the origin of neoplastic cells and their degree of differentiation. METHODS: Expression patterns for terminal differentiation markers were used to characterize tumor types and to study tumor progression in transgenic mouse models of mammary neoplasia (mice overexpressing Neu (Erbb2), Hras, Myc, Notch4, SV40-TAg, Tgfa, and Wnt1), in spontaneous mammary carcinomas, and in mammary neoplasms associated with infection by the mouse mammary tumor virus (MMTV). RESULTS: On the basis of the expression of terminal differentiation markers, three types of neoplasm were identified: first, simple carcinomas composed exclusively of cells with a luminal phenotype are characteristic of neoplasms arising in mice transgenic for Neu, Hras, Myc, Notch4, and SV40-TAg; second, 'complex carcinomas' displaying luminal and myoepithelial differentiation are characteristic of type P tumors arising in mice transgenic for Wnt1, neoplasms arising in mice infected by the MMTV, and spontaneous adenosquamous carcinomas; and third, 'carcinomas with epithelial to mesenchymal transition (EMT)' are a characteristic feature of tumor progression in Hras-, Myc-, and SV40-TAg-induced mammary neoplasms and PL/J and SJL/J mouse strains, and display de novo expression of myoepithelial and mesenchymal cell markers. In sharp contrast, EMT was not detected in papillary adenocarcinomas arising in BALB/cJ mice, spontaneous adenoacanthomas, neoplasms associated with MMTV-infection, or in neoplasms arising in mice transgenic for Neu and Wnt1. CONCLUSIONS: Immunohistochemical profiles of complex neoplasms are consistent with a stem cell origin, whereas simple carcinomas might originate from a cell committed to the luminal lineage. In addition, these results suggest that the initiating oncogenic events determine the morphologic features associated with cancer progression because EMT is observed only in certain types of neoplasm. BioMed Central 2004 2004-10-06 /pmc/articles/PMC1064077/ /pubmed/15535849 http://dx.doi.org/10.1186/bcr930 Text en Copyright © 2004 Mikaelian et al. licensee BioMed Central Ltd
spellingShingle Research Article
Mikaelian, Igor
Blades, Natalie
Churchill, Gary A
Fancher, Karen
Knowles, Barbara B
Eppig, Janan T
Sundberg, John P
Proteotypic classification of spontaneous and transgenic mammary neoplasms
title Proteotypic classification of spontaneous and transgenic mammary neoplasms
title_full Proteotypic classification of spontaneous and transgenic mammary neoplasms
title_fullStr Proteotypic classification of spontaneous and transgenic mammary neoplasms
title_full_unstemmed Proteotypic classification of spontaneous and transgenic mammary neoplasms
title_short Proteotypic classification of spontaneous and transgenic mammary neoplasms
title_sort proteotypic classification of spontaneous and transgenic mammary neoplasms
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1064077/
https://www.ncbi.nlm.nih.gov/pubmed/15535849
http://dx.doi.org/10.1186/bcr930
work_keys_str_mv AT mikaelianigor proteotypicclassificationofspontaneousandtransgenicmammaryneoplasms
AT bladesnatalie proteotypicclassificationofspontaneousandtransgenicmammaryneoplasms
AT churchillgarya proteotypicclassificationofspontaneousandtransgenicmammaryneoplasms
AT fancherkaren proteotypicclassificationofspontaneousandtransgenicmammaryneoplasms
AT knowlesbarbarab proteotypicclassificationofspontaneousandtransgenicmammaryneoplasms
AT eppigjanant proteotypicclassificationofspontaneousandtransgenicmammaryneoplasms
AT sundbergjohnp proteotypicclassificationofspontaneousandtransgenicmammaryneoplasms